123 related articles for article (PubMed ID: 23223556)
1. Mutational biosynthesis of a FK506 analogue containing a non-natural starter unit.
Ban YH; Lee JH; Gu GR; Lee B; Mo S; Kwon HJ; Yoon YJ
Mol Biosyst; 2013 May; 9(5):944-7. PubMed ID: 23223556
[TBL] [Abstract][Full Text] [Related]
2. Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP.
Kim DH; Ryu JH; Lee KS; Lee BM; Lee MO; Lim SK; Maeng PJ
Appl Microbiol Biotechnol; 2013 Jul; 97(13):5881-92. PubMed ID: 23392766
[TBL] [Abstract][Full Text] [Related]
3. Menaquinone biosynthesis in Escherichia coli: identification of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate as a novel intermediate and re-evaluation of MenD activity.
Jiang M; Cao Y; Guo ZF; Chen M; Chen X; Guo Z
Biochemistry; 2007 Sep; 46(38):10979-89. PubMed ID: 17760421
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography-mass spectrometry characterization of FK506 biosynthetic intermediates in Streptomyces clavuligerus KCTC 10561BP.
Park JW; Mo SJ; Park SR; Ban YH; Yoo YJ; Yoon YJ
Anal Biochem; 2009 Oct; 393(1):1-7. PubMed ID: 19539594
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate.
Andexer JN; Kendrew SG; Nur-e-Alam M; Lazos O; Foster TA; Zimmermann AS; Warneck TD; Suthar D; Coates NJ; Koehn FE; Skotnicki JS; Carter GT; Gregory MA; Martin CJ; Moss SJ; Leadlay PF; Wilkinson B
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4776-81. PubMed ID: 21383123
[TBL] [Abstract][Full Text] [Related]
6. Determination of the stereochemistry of 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylate, a key intermediate in menaquinone biosynthesis.
Jiang M; Chen M; Cao Y; Yang Y; Sze KH; Chen X; Guo Z
Org Lett; 2007 Nov; 9(23):4765-7. PubMed ID: 17956107
[TBL] [Abstract][Full Text] [Related]
7. Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP.
Mo S; Yoo YJ; Ban YH; Lee SK; Kim E; Suh JW; Yoon YJ
Appl Environ Microbiol; 2012 Apr; 78(7):2249-55. PubMed ID: 22267670
[TBL] [Abstract][Full Text] [Related]
8. The biosynthetic pathway of FK506 and its engineering: from past achievements to future prospects.
Ban YH; Park SR; Yoon YJ
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):389-400. PubMed ID: 26342319
[TBL] [Abstract][Full Text] [Related]
9. Origin of p-aminobenzoic acid from chorismic rather than iso-chorismic acid in Enterobacter aerogenes and Streptomyces species.
Johanni M; Hofmann P; Leistner E
Arch Biochem Biophys; 1989 Jun; 271(2):495-501. PubMed ID: 2786373
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of FK506 production by engineering secondary pathways of Streptomyces tsukubaensis and exogenous feeding strategies.
Huang D; Xia M; Li S; Wen J; Jia X
J Ind Microbiol Biotechnol; 2013 Sep; 40(9):1023-37. PubMed ID: 23779221
[TBL] [Abstract][Full Text] [Related]
11. In vivo instability of chorismate causes substrate loss during fermentative production of aromatics.
Winter G; Averesch NJ; Nunez-Bernal D; Krömer JO
Yeast; 2014 Sep; 31(9):333-41. PubMed ID: 24981409
[TBL] [Abstract][Full Text] [Related]
12. Chemical and biological characterization of two FK506 analogs produced by targeted gene disruption in Streptomyces sp. MA6548.
Shafiee A; Motamedi H; Dumont FJ; Arison BH; Miller RR
J Antibiot (Tokyo); 1997 May; 50(5):418-23. PubMed ID: 9207912
[TBL] [Abstract][Full Text] [Related]
13. How an enzyme surmounts the activation energy barrier.
Schowen RL
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):11931-2. PubMed ID: 14530397
[No Abstract] [Full Text] [Related]
14. On-the-path random walk sampling for efficient optimization of minimum free-energy path.
Chen M; Yang W
J Comput Chem; 2009 Aug; 30(11):1649-53. PubMed ID: 19462399
[TBL] [Abstract][Full Text] [Related]
15. Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011.
Mo S; Lee SK; Jin YY; Oh CH; Suh JW
Appl Microbiol Biotechnol; 2013 Apr; 97(7):3053-62. PubMed ID: 23053074
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CalS9 in the biosynthesis of UDP-xylose and the production of xylosyl-attached hybrid compound.
Simkhada D; Oh TJ; Pageni BB; Lee HC; Liou K; Sohng JK
Appl Microbiol Biotechnol; 2009 Jul; 83(5):885-95. PubMed ID: 19290519
[TBL] [Abstract][Full Text] [Related]
17. Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506).
Barreiro C; Martínez-Castro M
Appl Microbiol Biotechnol; 2014 Jan; 98(2):497-507. PubMed ID: 24272367
[TBL] [Abstract][Full Text] [Related]
18. Chorismatases - the family is growing.
Grüninger MJ; Buchholz PCF; Mordhorst S; Strack P; Müller M; Hubrich F; Pleiss J; Andexer JN
Org Biomol Chem; 2019 Feb; 17(8):2092-2098. PubMed ID: 30706936
[TBL] [Abstract][Full Text] [Related]
19. Origin of the allyl group in FK506 biosynthesis.
Goranovic D; Kosec G; Mrak P; Fujs S; Horvat J; Kuscer E; Kopitar G; Petkovic H
J Biol Chem; 2010 May; 285(19):14292-300. PubMed ID: 20194504
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and plasticity of isochorismate pyruvate lyase: a computational study.
Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
J Am Chem Soc; 2009 Nov; 131(44):16156-61. PubMed ID: 19835359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
